More Isn't Better When it Comes to Cholesterol Lowering Drugs - KCBD NewsChannel 11 Lubbock

8/30/04

More Isn't Better When it Comes to Cholesterol Lowering Drugs

New research is casting doubt on the theory that more is better when it comes to cholesterol lowering drugs. Specifically, the study found a high dose of 80 milligrams of Zocor, worked only slightly better than a lower dose of 40 milligrams when it came to preventing subsequent problems in patients who've suffered a heart attack. Instead it found the higher dose actually caused more painful side effects in the muscles. Researchers say the findings aren't bad, just worth discussing with your doctor.

"I think that it doesn't suggest that the statins aren't working, it simply raises the question about how high do you go with this particular drug, and it turns out that the 80-milligram dose of Zocor didn't gain any additional benefits," says Dr. Steven Nissen, a Cardiologist.

The study was led by researchers at UT Southwestern Medical Center in Dallas. It was due to be published in the Journal of the American Medical Association, but was released early because it was presented today at the European Society of Cardiology meeting in Munich, Germany. The study was funded by Zocor's manufacturer, Merck & Co, Inc.

Powered by WorldNow

5600 Avenue A
Lubbock, TX. 79404

FCC Public File
publicfile@kcbd.com
806-744-1414
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KCBD. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.